 |
C1 esterase inhibitor (Human) |
|---|---|
| Trade Name | Cinryze |
| Orphan Indication | Acute antibody mediated rejection following kidney transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2016-11-30 00:00:00 |
| Sponsor | Shire ViroPharma, Inc.;300 Shire Way;Lexington, Massachusetts, 02421 |
